Agenda

Please note: all timings are listed in EDT, to view start times in your local timezone, please click here.

Join us in person or virtually

  1. Registration and coffee

  2. Welcome and introduction

  3. Session 1: Global overviews
  4. Preparing for the future and protecting companies from collateral liability 

    • the need to engage in legally protected due diligence;
    • managing the tension between disclosure obligations and minimizing liability; and
    • strategies to minimize collateral PFAS liability
    Lynn L. Bergeson Lynn L. Bergeson
    Managing Partner, Bergeson & Campbell, USA
  5. Managing global PFAS restrictions - how to find the common denominator globally

    • review international instruments addressing PFAS substances;
    • review PFAS measures in place in selected jurisdictions; and
    • review global compliance strategies.
    Ruxandra Cana Ruxandra Cana
    Partner, Steptoe LLP
  6. Q&A session

  7. Refreshment break

  8. Session 2: Regulatory developments from the US
  9. State level overview: Updates from New York

    • pollution prevention approach to PFAS;​
    • recent NYS actions on PFAS; and​
      • PFAS in Food Packaging Law​
      • PFAS in Apparel Law​
    • other PFAS restrictions.
    Conor Shea Conor Shea
    Supervisor, Pollution Prevention Unit, New York State Department of Environmental Conservation
  10. Updates from Maine and Minnesota

    Martha E. Marrapese Martha E. Marrapese
    Partner, Wiley Rein LLP, USA
  11. Technical considerations and the expanding PFAS regulations

    • key technical considerations that may be important when addressing or complying with the expanding PFAS regulations:
      • consideration for PFAS “background” in investigations and studies; and,
      • identifying sources of PFAS in products or in the environment.
    Jaana Pietari Jaana Pietari
    Senior Managing Consultant, Ramboll
  12. Q&A session

  13. Lunch and networking

  14. Welcome back

  15. Session 3: Developments elsewhere
  16. EU Regulation: update on the PFAS restriction proposal and Member States developments

    • EU PFAS restriction proposal: where we stand, what is to be expected;
    • (Sectorial) restrictions at Member States level; and
    • the emerging litigation threat at Member States level: are the EU and the US converging?
    Thomas Delille Thomas Delille
    Partner, Squire Patton Boggs, Belgium
  17. PFAS: regulatory update in Canada

    Canada has been working diligently in defining and collecting information on perfluoroalkyl and polyfluoroalkyl substances (PFAS). This presentation will talk about:

    • how PFAS are defined in Canada;
    • potential issues surrounding PFAS in Canada; and
    • status of the regulations in Canada.
    Dan Bastien Dan Bastien
    Senior Director and Head of Chemicals, Intertek, Canada
  18. Q&A session

  19. Refreshment break

  20. Session 4: Other recent US Developments
  21. Recent US Litigation

    • PFAS greenwashing claims update;
    • class action litigation and medical monitoring claims; and,
    • impact of EPA and state regulatory actions on litigation.
    John Gardella John Gardella
    Co-Owner / Attorney, CMBG3 Law, USA
  22. Update on the PFAS reporting rule

    • the management of PFAS in the US including PMN and SNUNs;
    • the reporting rule; and,
    • common state rules.
    Rose Passarella Rose Passarella
    Director - Chemicals Group, Intertek Assuris, USA
  23. Assessing and managing PFAS risk / liability

    • as a manufacturer, consumer, investor, or lender, it is important to understand your PFAS risk profile and how to manage potential PFAS liabilities;
    • defining and managing your company’s PFAS footprint is a necessity as this space is ever expanding with new regulatory drivers that have to be understood, in a company’s business context and in concert with each other; and,
    • the presentation will focus on the objectives of a PFAS liability assessment and a methodology on how to achieve these objectives, including the overall due diligence steps needed, the approach to identifying and prioritizing risks, developing risk ratings, and developing a plan to manage and/or mitigate the risks.
    Elizabeth Denly Elizabeth Denly
    PFAS Initiative Leader & Chemistry Director, TRC
  24. Case study

  25. Q&A session

  26. Networking drinks reception

  27. Close of conference